MedTrace Logo

Articaine vs Dexmedetomidine Supplemented Articaine

NCT04171349 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-11-20

No results posted yet for this study

Summary

The aim of this study to test efficacy of adding dexmedetomidine to articaine on sensory, motor and duration of analgesia during hemodialysis fistula creation under ultrasound guided supraclavicular block

Conditions

  • Renal Failure

Interventions

DRUG

Articaine

Vial

DRUG

Dexmedetomidine

Vial

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Galal Mo Professor, Doctor · Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-10-01
Completion
2019-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171349 on ClinicalTrials.gov